James Whitehorn | GMC# 6053701

  • University College London
  • Clinical Lecturer Infectious Diseases

Archived Declarations


Feb. 1, 2018

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Janssen Consultancy fees related to dengue antiviral development project 4